Systematic Financial Management LP decreased its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 42.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 17,025 shares of the company’s stock after selling 12,620 shares during the period. Systematic Financial Management LP’s holdings in Prestige Consumer Healthcare were worth $591,000 at the end of the most recent quarter.
Several other hedge funds have also recently made changes to their positions in the company. Eqis Capital Management Inc. bought a new stake in Prestige Consumer Healthcare in the 3rd quarter valued at $296,000. BBVA USA Bancshares Inc. acquired a new position in shares of Prestige Consumer Healthcare during the 3rd quarter worth about $326,000. Massachusetts Financial Services Co. MA increased its stake in shares of Prestige Consumer Healthcare by 28.2% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 792,320 shares of the company’s stock worth $27,486,000 after purchasing an additional 174,117 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Prestige Consumer Healthcare by 100.6% during the 3rd quarter. Tower Research Capital LLC TRC now owns 1,657 shares of the company’s stock worth $57,000 after purchasing an additional 831 shares during the last quarter. Finally, Tibra Equities Europe Ltd acquired a new position in shares of Prestige Consumer Healthcare during the 3rd quarter worth about $465,000.
In related news, insider Paton Brett 586,594 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. 1.14% of the stock is owned by corporate insiders.
Shares of NYSE:PBH traded up $0.57 on Thursday, reaching $37.57. 243,235 shares of the company’s stock were exchanged, compared to its average volume of 445,132. The company has a fifty day moving average of $36.05 and a 200-day moving average of $32.93. Prestige Consumer Healthcare Inc has a twelve month low of $26.25 and a twelve month high of $39.43. The company has a current ratio of 2.08, a quick ratio of 1.22 and a debt-to-equity ratio of 1.60. The company has a market capitalization of $1.89 billion, a price-to-earnings ratio of 13.51, a PEG ratio of 2.06 and a beta of 0.87.
Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, October 31st. The company reported $0.68 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.02. Prestige Consumer Healthcare had a negative net margin of 3.56% and a positive return on equity of 12.68%. The company had revenue of $238.07 million during the quarter, compared to the consensus estimate of $237.17 million. During the same quarter in the prior year, the firm posted $0.65 EPS. The firm’s quarterly revenue was down .5% on a year-over-year basis. As a group, equities…